Article
A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture
20 Apr 2019
Abstract excerpt
Atypical femoral fracture is a well-documented adverse reaction to bisphosphonates. It is strongly related to duration of bisphosphonate use, and the risk declines rapidly after drug withdrawal. The mechanism behind bisphosphonate-associated atypical femoral fracture is unclear, but a genetic predisposition has been suggested. With the aim to identify common genetic variants that could be used for preemptive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
